TrialJAMA oncology2019

Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial.

MinKe He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.